MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy

Go back to MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy
(NASDAQ: INKT) Delayed: 10.71 +0.65 (6.46%)
Previous Close $10.06    52 Week High $ 
Open $10.64    52 Week Low $ 
Day High $11.68    P/E N/A 
Day Low $10.18    EPS $ 
Volume 29,409